These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29703171)
41. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study. Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707 [TBL] [Abstract][Full Text] [Related]
43. Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States. Baliga S; Yildiz VO; Bazan J; Palmer JD; Jhawar SR; Konieczkowski DJ; Grecula J; Blakaj DM; Mitchell D; Henson C; Hu K; Yamoah K; Gamez ME Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980667 [TBL] [Abstract][Full Text] [Related]
44. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery. Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328 [TBL] [Abstract][Full Text] [Related]
45. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634 [TBL] [Abstract][Full Text] [Related]
51. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients. Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399 [TBL] [Abstract][Full Text] [Related]
52. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. Spraker MB; Bair E; Bair R; Connell PP; Mahmood U; Koshy M J Thorac Oncol; 2013 Feb; 8(2):147-51. PubMed ID: 23263688 [TBL] [Abstract][Full Text] [Related]
53. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity]. Li Y; Niu XH; Xu HR Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413 [TBL] [Abstract][Full Text] [Related]
54. The impact of race and socioeconomic status on stage IV colorectal cancer survival. Cheong JY; Vu JV; Connelly TM; Tabbaa J; Gunter R; Liska D; Gorgun E; Steele SR; Valente MA Am J Surg; 2023 Mar; 225(3):523-526. PubMed ID: 36586755 [TBL] [Abstract][Full Text] [Related]
55. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma. Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212 [TBL] [Abstract][Full Text] [Related]
56. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Al-Refaie WB; Tseng JF; Gay G; Patel-Parekh L; Mansfield PF; Pisters PW; Yao JC; Feig BW Cancer; 2008 Aug; 113(3):461-9. PubMed ID: 18553367 [TBL] [Abstract][Full Text] [Related]
57. Small soft tissue sarcomas do metastasize: identification of high-risk tumors. Styring E; Hartman L; Nilbert M; Rissler P; Rydholm A; von Steyern FV Ann Surg Oncol; 2014 Nov; 21(12):4020-5. PubMed ID: 24903235 [TBL] [Abstract][Full Text] [Related]
58. Disparities in Survival and NCCN Guideline-Concordant Care in Patients With Extremity Soft Tissue Sarcoma. Dunlop HM; Bende B; Ruff SM; Kim A; Fisher JL; Grignol VP; Contreras CM; Obeng-Gyasi S; Konieczkowski DJ; Pawlik TM; Pollock RE; Beane JD J Natl Compr Canc Netw; 2024 Feb; 22(1):26-33. PubMed ID: 38394772 [TBL] [Abstract][Full Text] [Related]
59. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma. Kang S; Han I; Lee S; Kim W; Kim H Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741 [TBL] [Abstract][Full Text] [Related]